Your Health, We Care

Home >Drug List>Daraxonrasib>Indications of Daraxonrasib

Daraxonrasib(LuciDarax)

Release date: 2026-10-10 10:32:50     Recommended: 1

Daraxonrasib for adults with metastatic pancreatic adenocarcinoma who have had ≥1 prior therapy or cannot receive combination anticancer therapy.